Before you go!

Sign up for the FREE weekly email newsletter from the publishers of American Nurse Today. You’ll get breaking news features, exclusive investigative stories, and more — delivered to your inbox.

Sign up today!

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Early, intensive therapy for type 2 diabetes can slow progression

A study of 58 patients with type 2 diabetes found that early and intensive therapy helped preserve beta cell function for 3.5 years. In the study, published in Diabetes Care, patients with newly diagnosed type 2 diabetes received insulin and metformin for 3 months, then were randomly assigned to one of two groups: 1) insulin plus metformin and 2) triple oral therapy (metformin, glyburide, and pioglitazone). Read more.

Leave a Reply

You have to agree to the comment policy.


Test Your Nursing Knowledge

Answer this interactive quiz to be entered to win a gift card.

  • This field is for validation purposes and should be left unchanged.

Insights Blog

Today’s News in Nursing